Pivotal Health
+46%
est. 2Y upside i
Rank
#1819
Sector
Healthcare Technology
Est. Liquidity
~6Y
Data Quality
Data: LowPivotal Health has a credible setup — Bessemer-backed, large fast-growing TAM, and a strong regulatory moat via No Surprises Act IDR — but every critical financial data point (revenue, valuation, funding raised) is null, making it impossible to independently evaluate the preference stack or entry price.
Last updated: May 14, 2026
Pivotal Health captures 1-2% of its $20B SAM (~$200-400M ARR) within 5-7 years at a 10-12x revenue multiple, reaching a $2-4B valuation; within 2 years, a Series B priced at 3-4x today's unknown baseline and strong ARR trajectory would yield roughly 180% paper upside for employees entering now.
Preference Stack Risk
moderateFunding Intensity
0%Total funding and current valuation are both null; with Bessemer as lead on a likely Seed-to-Series A stage company, estimated preferences of $5-20M against an unknown valuation make the overhang unquantifiable — treat as at least moderate until the cap table is disclosed.
Dilution Risk
highAs a 22-person company almost certainly pre-Series B, employees should expect 40-60%+ dilution from future financing rounds (Series A, B, C) before any liquidity event.
Secondary Liquidity
noneNo secondary market exists for shares in a 22-person private company at this stage; employees should expect full lockup for an estimated 5-7 years until an IPO or acquisition.
Questions to Ask at the Interview
Strategic questions based on Pivotal Health's data — designed to show you've done your homework.
- 1
“How has IDR claim volume and provider win-rate trended month-over-month since launch, and what share of submitted disputes does Pivotal Health successfully resolve in favor of providers?”
- 2
“What is the current ARR run rate and average revenue per resolved claim, and how does the success-based fee structure hold up if CMS narrows the categories of qualifying No Surprises Act disputes?”
- 3
“What is the current 409A valuation, total liquidation preference stack, and fully diluted cap table — and has the board discussed any secondary liquidity program or tender offer for employees?”
Community
Valuation Sentiment
Our model estimates +46% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.